Comparison of the effects of new and conventional hormone replacement therapies on left ventricular diastolic function in healthy postmenopausal women: a Doppler and ultrasonic backscatter study

  • Hamza Duygu
  • Levent Akman
  • Filiz Ozerkan
  • Fuat Akercan
  • Mehdi Zoghi
  • Sanem Nalbantgil
  • Umit Erturk
  • Azem Akilli
  • Remzi Onder
  • Mustafa Akin
Original Paper


We aimed to compare the effects of new treatment modalities to conventional hormone replacement therapy (HRT) on left ventricular (LV) diastolic function, by means of conventional and tissue Doppler echocardiography and the myocardial integrated backscatter (IBS) in postmenopausal women. One hundred and fifty healthy postmenopausal women were included in this study. Subjects were assigned to one of the five groups receiving 1 year of treatment (estrogen, estrogen plus progesterone, raloxifene, tibolone or placebo). E and A wave velocity, E/A ratio, isovolumic relaxation time (IVRT), deceleration time (DT), peak early (Em) diastolic mitral annular velocity, E/Em ratio, the cyclic variation of integrated backscatter (CVIBS) and the mean value of the IBS signal (MIBS) were determined before and 12 months after therapy. E (76 ± 10 vs. 98 ± 8 cm/s, P = 0.0001 and 78 ± 10 vs. 90 ± 12 cm/s, P = 0.02, respectively), Em (14.3 ± 2.4 vs. 16.4 ± 2.5 cm/s, P = 0.001 and 15.1 ± 3.4 vs. 16.2 ± 3.5 cm/s, P = 0.01, respectively), and E/A ratio (1.15 ± 0.3 vs. 1.42 ± 0.4, P = 0.0001 and 1.0 ± 0.2 vs. 1.22 ± 0.2, P = 0.01, respectively) were increased significantly compared to pretreatment in both estrogen and raloxifene groups while DT, A, E/Em, and IVRT were significantly decreased. A significant increase in CVIBS and decrease in MIBS were detected 12 months after estrogen and raloxifene administration while no significant changes were observed in other groups. Changes in the MIBS and CVIBS were found to be independently associated with the observed changes in the diastolic function indexes during therapy. Both estrogen and raloxifene regimens may improve LV diastolic functions in healthy postmenopausal women. This improvement may be a result of direct cardiac effects on LV myocardium.


Menopause Hormone replacement therapy Diastolic function Integrated backscatter 


  1. 1.
    Pines A, Fisman EZ, Drory Y et al (1992) Menopause-induced changes in Doppler-derived parameters of aortic flow in healthy women. Am J Cardiol 69:1104–1106. doi:10.1016/0002-9149(92)90877-2 PubMedCrossRefGoogle Scholar
  2. 2.
    Pines A, Fisman EZ, Shemesh J et al (1992) Menopause-related changes in left ventricular function in healthy women. Cardiology 80:413–416. doi:10.1159/000175033 PubMedCrossRefGoogle Scholar
  3. 3.
    Tresch DD, McGough MF (1995) Heart failure with normal systolic function: a common disorder in older people. J Am Geriatr Soc 43:1035–1042PubMedGoogle Scholar
  4. 4.
    Hulley S, Grady D, Bush T et al (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women: heart and estrogen progestin replacement study (HERS) research group. JAMA 280:605–613. doi:10.1001/jama.280.7.605 PubMedCrossRefGoogle Scholar
  5. 5.
    Lemay A (2002) The relevance of the Women’s Health Initiative results on combined hormone replacement therapy in clinical practice. J Obstet Gynaecol Can 24(9):711–715PubMedGoogle Scholar
  6. 6.
    Hall CS, Scott MJ, Lanza GM et al (2000) The extracellular matrix is an important source of ultrasound backscatter from myocardium. J Acoust Soc Am 107:612–619. doi:10.1121/1.428327 PubMedCrossRefGoogle Scholar
  7. 7.
    Duygu H, Ozerkan F, Zoghi M et al (2007) Objective ischemic evidence in patients with myocardial bridging: ultrasonic tissue characterization with dobutamine stress integrated backscatter. J Am Soc Echocardiogr 20(6):717–723. doi:10.1016/j.echo.2006.11.013 PubMedCrossRefGoogle Scholar
  8. 8.
    O’Brien PD, O’Brien WD Jr, Rhyne TL et al (1995) Relation of ultrasonic backscatter and acoustic propagation properties to myofibrillar length and myocardial thickness. Circulation 91(1):171–175PubMedGoogle Scholar
  9. 9.
    Schiller NB, Shah PM, Crawford M et al (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 2(5):358–367PubMedGoogle Scholar
  10. 10.
    Owan TE, Hodge DO, Herges RM et al (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355(3):251–259. doi:10.1056/NEJMoa052256 PubMedCrossRefGoogle Scholar
  11. 11.
    Yturralde RF, Gaasch WH (2005) Diagnostic criteria for diastolic heart failure. Prog Cardiovasc Dis 47(5):314–319. doi:10.1016/j.pcad.2005.02.007 PubMedCrossRefGoogle Scholar
  12. 12.
    Kangro T, Henriksen E, Jonason T et al (1995) Effect of menopause on left ventricular filling in 50 year old women. Am J Cardiol 76:1093–1096. doi:10.1016/S0002-9149(99)80310-5 PubMedCrossRefGoogle Scholar
  13. 13.
    Losordo DW, Kearney M, Kim EA et al (1994) Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89:1501–1510PubMedGoogle Scholar
  14. 14.
    Voutilainen S, Hippeläinen M, Hulkko S et al (1993) Left ventricular diastolic function by Doppler echocardiography in relation to hormonal replacement therapy in healthy postmenopausal women. Am J Cardiol 71:614–617. doi:10.1016/0002-9149(93)90525-H PubMedCrossRefGoogle Scholar
  15. 15.
    Gökçe M, Karahan B, Erdöl C et al (2003) Left ventricular diastolic function assessment by tissue Doppler echocardiography in relation to hormonal replacement therapy in postmenopausal women with diastolic dysfunction. Am J Ther 10(2):104–111. doi:10.1097/00045391-200303000-00005 PubMedCrossRefGoogle Scholar
  16. 16.
    Yildirir A, Yarali H, Kabakci G et al (2001) Hormone replacement therapy to improve left ventricular diastolic functions in healthy postmenopausal women. Int J Gynaecol Obstet 75(3):273–278. doi:10.1016/S0020-7292(01)00469-6 PubMedCrossRefGoogle Scholar
  17. 17.
    Taskin O, Muderrisoglu H, Akar M et al (2004) Comparison of the effects of tibolone and estrogen replacement therapy on echocardiographic basic cardiac functions in post-menopausal women: a randomized placebo controlled study. Maturitas 48(4):354–359. doi:10.1016/j.maturitas.2003.08.014 PubMedCrossRefGoogle Scholar
  18. 18.
    Collins P, Rosano GM, Jiang C et al (1993) Cardiovascular protection by estrogen—a calcium antagonist effect? Lancet 341(8855):1264–1265. doi:10.1016/0140-6736(93)91158-I PubMedCrossRefGoogle Scholar
  19. 19.
    Gangar KF, Vyas S, Whitehead M et al (1991) Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 338:839–842. doi:10.1016/0140-6736(91)91500-T PubMedCrossRefGoogle Scholar
  20. 20.
    Gisclard V, Miller VM, Vanhoutte PM et al (1988) Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 244(1):19–22PubMedGoogle Scholar
  21. 21.
    Chester AH, Jiang C, Borland JA et al (1995) Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Coron Artery Dis 6:417–422. doi:10.1097/00019501-199505000-00009 PubMedCrossRefGoogle Scholar
  22. 22.
    Grohé C, Kahlert S, Löbbert K et al (1997) Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 416(1):107–112. doi:10.1016/S0014-5793(97)01179-4 PubMedCrossRefGoogle Scholar
  23. 23.
    Rosano GMC, Sarrel PM, Chierchia SL, et al. (1996) Medroxyprogesterone acetate but nor natural progesterone reverses the effect of estradiol 17 beta upon exercise induced myocardial ischemia. A double-blind cross-over study. In: 8th International Congress on the Menopause, Sydney, Abstract Book F126Google Scholar
  24. 24.
    Pérez JE, McGill JB, Santiago JV et al (1992) Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol 19:1154–1162PubMedCrossRefGoogle Scholar
  25. 25.
    Mimbs JW, O’Donnell M, Bauwens D et al (1980) The dependence of ultrasonic attenuation and backscatter on collagen content in dog and rabbit hearts. Circ Res 47(1):49–58PubMedGoogle Scholar
  26. 26.
    Picano E, Pelosi G, Marzilli M et al (1990) In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans. Circulation 81:58–64PubMedGoogle Scholar
  27. 27.
    Wickline SA, Thomas LJ 3rd, Miller JG et al (1985) The dependence of myocardial ultrasonic integrated backscatter on contractile performance. Circulation 72(1):183–192PubMedGoogle Scholar
  28. 28.
    Ho YL, Lin LC, Yen ML et al (2002) Assessment of menopause-induced myocardial changes by integrated backscatter during inotropic stimulation and atropine injection. Ultrasound Med Biol 28(7):889–895. doi:10.1016/S0301-5629(02)00529-X PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, B.V. 2009

Authors and Affiliations

  • Hamza Duygu
    • 1
  • Levent Akman
    • 2
  • Filiz Ozerkan
    • 3
  • Fuat Akercan
    • 2
  • Mehdi Zoghi
    • 3
  • Sanem Nalbantgil
    • 3
  • Umit Erturk
    • 3
  • Azem Akilli
    • 3
  • Remzi Onder
    • 3
  • Mustafa Akin
    • 3
  1. 1.Department of CardiologyAtaturk Training and Research HospitalYesilyurt, IzmirTurkey
  2. 2.Department of Obstetrics and GynecologyEge University Medical FacultyIzmirTurkey
  3. 3.Department of CardiologyEge University Medical FacultyIzmirTurkey

Personalised recommendations